Erratum to: SEOM guidelines for the treatment of gastric cancer 2015

by Martin-Richard, M., Custodio, A., García-Girón, C., Grávalos, C., Gomez, C., Jimenez-Fonseca, P., Manzano, J. L., Pericay, C., Rivera, F., Carrato, A.
Published 2016

Seom guidelines for the treatment of gastric cancer 2015

by Martin-Richard, M., Custodio, A., García-Girón, C., Grávalos, C., Gomez, C., Jimenez-Fonseca, P., Manzano, J. L., Pericay, C., Rivera, F., Carrato, A.
Published 2015

First-line bevacizumab and capecitabine–oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study

by Feliu, J, Salud, A, Safont, M J, García-Girón, C, Aparicio, J, Vera, R, Serra, O, Casado, E, Jorge, M, Escudero, P, Bosch, C, Bohn, U, Pérez-Carrión, R, Carmona, A, Martínez-Marín, V, Maurel, J
Published 2014

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study

by Roy, A, Cunningham, D, Hawkins, R, Sörbye, H, Adenis, A, Barcelo, J-R, Lopez-Vivanco, G, Adler, G, Canon, J-L, Lofts, F, Castanon, C, Fonseca, E, Rixe, O, Aparicio, J, Cassinello, J, Nicolson, M, Mousseau, M, Schalhorn, A, D'Hondt, L, Kerger, J, Hossfeld, D K, Garcia Giron, C, Rodriguez, R, Schoffski, P, Misset, J-L
Published 2012